Evidence map›Paper›PMID 37672080›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2024

Cellular and molecular antiproliferative effects in 2D monolayer and 3D-cultivated HT-29 cells treated with zerumbone.

Nayane de Oliveira Silva, Luan Vitor Alves de Lima, Liana Martins de Oliveira, Matheus Felipe da Silva, Amanda Passuello de Aguiar, Simone Cristine Semprebon, Phelipe Oliveira Favaron, Sandra Regina Lepri, Ingrid Felicidade, Mario Sergio Mantovani

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Nayane de Oliveira SilvaDepartment of General Biology, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil.
Luan Vitor Alves de LimaDepartment of General Biology, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil.
Liana Martins de OliveiraDepartment of General Biology, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil.
Matheus Felipe da SilvaDepartment of General Biology, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil.
Amanda Passuello de AguiarDepartment of General Biology, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil.
Simone Cristine SemprebonDepartment of General Biology, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil.
Phelipe Oliveira FavaronDepartment of General Biology, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil.
Sandra Regina LepriDepartment of General Biology, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil.
Ingrid FelicidadeDepartment of General Biology, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil.
Mario Sergio MantovaniDepartment of General Biology, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil. biomsm@uel.br.ORCID 0000-0001-5268-6508
Universidade Estadual de Londrina · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zerumbone (ZER) is a phytochemical isolated from plants of the Zingiberaceae family. Numerous studies have demonstrated its diverse pharmacological properties, particularly its potent antitumorigenic activity. This study aimed to assess the antiproliferative effects of ZER on HT-29 cells cultivated in both two-dimensional (2D) monolayer and three-dimensional (3D) spheroid culture systems. The evaluation of growth (size), cell death, and cell cycle arrest in 3D spheroid HT-29 cells was correlated with mRNA expression data. Treatment of 2D cells revealed that ZER exhibited cytotoxicity at concentrations above 30 µM, and an IC50 of 83.54 µM (24-h post-ZER treatment) effectively suppressed cell migration. In the 3D model, ZER induced an increase in spheroid volume over a 72-h period attributed to disaggregation and reconfiguration of characteristic zones. Analysis of cell death demonstrated a significant rise in apoptotic cells after 24 h of ZER treatment, along with cell cycle arrest in the G1 phase. Furthermore, ZER treatment resulted in alterations in mRNA expression, affecting key signaling pathways involved in cell death (BCL2 and BBC3), endoplasmic reticulum stress (ERN1), DNA damage (GADD45A), cell cycle regulation (CDKN1A, NFKB1, MYC, and TP53), and autophagy (BECN1 and SQSTM1). These findings suggested that ZER holds promise as a potential candidate for the development of novel anticancer agents that can modulate crucial cell signaling pathways. Additionally, the use of the 3D culture system proved to be a valuable tool in our investigation.

Indexed as

Antineoplastic AgentsSesquiterpenesApoptosisCell Line, TumorHT29 CellsHumansRNA, MessengerAntineoplastic AgentsRNA, MessengerSesquiterpeneszerumbone3D cultureAnticancerGene expressionPhytochemicalZerumbone

Identifiers

PMID37672080
OpenAlexW4386466644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.